Capital Advisory Group Advisory Services’s abrdn Life Sciences Investors HQL Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5	Closed	-$88	–	407
2018 Q3	$0	Buy	+5	New	+$99	﹤0.01%	378
2018 Q2	–	Sell	-255	Closed	-$5K	–	362
2018 Q1	$5K	Buy	+255	New	+$5.11K	﹤0.01%	271

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Capital Advisory Group Advisory Services's HQL Position: Q4 2018 in Review

Capital Advisory Group Advisory Services sold out of abrdn Life Sciences Investors (HQL) in Q4 2018, closing a stake of 5 shares — an estimated $88 sold.

Capital Advisory Group Advisory Services first reported a position in HQL in Q1 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2018. 59 funds tracked by Wall St. Rank hold HQL as of Q4 2018.

Capital Advisory Group Advisory Services reported no remaining abrdn Life Sciences Investors position as of Q4 2018 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 5 abrdn Life Sciences Investors shares in Q4 2018, an estimated $88.
Capital Advisory Group Advisory Services first reported a position in abrdn Life Sciences Investors in Q1 2018 and held it in 2 quarters.
Capital Advisory Group Advisory Services's abrdn Life Sciences Investors position peaked at $5K in Q1 2018.
59 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2018.

Based on Capital Advisory Group Advisory Services's 13F filing for Q4 2018, filed 28 May 2020.